These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27474994)

  • 21. Impact of the Mass Drug Administration for malaria in response to the Ebola outbreak in Sierra Leone.
    Aregawi M; Smith SJ; Sillah-Kanu M; Seppeh J; Kamara AR; Williams RO; Aponte JJ; Bosman A; Alonso P
    Malar J; 2016 Sep; 15():480. PubMed ID: 27646649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries.
    Overbosch D
    J Travel Med; 2003 May; 10 Suppl 1():S16-20; discussion S21-3. PubMed ID: 12737756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: retrospective observational data.
    Zuckerman JN; Batty AJ; Jones ME
    Travel Med Infect Dis; 2009 Nov; 7(6):329-36. PubMed ID: 19945009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults.
    Petersen E
    J Travel Med; 2003 May; 10 Suppl 1():S13-5; discussion S21. PubMed ID: 12737755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
    Deye GA; Miller RS; Miller L; Salas CJ; Tosh D; Macareo L; Smith BL; Fracisco S; Clemens EG; Murphy J; Sousa JC; Dumler JS; Magill AJ
    Clin Infect Dis; 2012 Jan; 54(2):232-9. PubMed ID: 22052893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers.
    Petersen E; Ronne T; Ronn A; Bygbjerg I; Larsen SO
    J Travel Med; 2000; 7(2):79-84. PubMed ID: 10759574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL
    J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of adherence to atovaquone-proguanil prophylaxis in travelers.
    DePetrillo JC; Singer C; Bergagnini IA; Kolakowski P; Edwards B; Smith MA
    J Travel Med; 2010; 17(4):217-20. PubMed ID: 20636593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A survey on outcomes of accidental atovaquone-proguanil exposure in pregnancy.
    Tan KR; Fairley JK; Wang M; Gutman JR
    Malar J; 2018 May; 17(1):198. PubMed ID: 29764439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Malaria prophylaxis for long-term travellers and expatriates].
    Kurtzhals JA; Vestergaard LS
    Ugeskr Laeger; 2005 Oct; 167(42):3988-92. PubMed ID: 16232398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-malarial chemoprophylaxis following evacuation from Afghanistan.
    Keene DD; Tong JL; Roughton S; Fadden SJ
    J R Army Med Corps; 2012 Mar; 158(1):38-40; discussion 40. PubMed ID: 22545372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability of doxycycline monohydrate salt vs. chloroquine-proguanil in malaria chemoprophylaxis.
    Pagès F; Boutin JP; Meynard JB; Keundjian A; Ryfer S; Giurato L; Baudon D
    Trop Med Int Health; 2002 Nov; 7(11):919-24. PubMed ID: 12390596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014-15 Ebola virus disease response: an economic analysis.
    Carias C; Greening B; Campbell CG; Meltzer MI; Hamel MJ
    Lancet Infect Dis; 2016 Apr; 16(4):449-58. PubMed ID: 26706716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atovaquone-proguanil chemoprophylaxis in the era of Tafenoquine.
    Meltzer E; Schwartz E
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30535377
    [No Abstract]   [Full Text] [Related]  

  • 35. Malaria prophylaxis during military operations in Thailand.
    Shanks GD; Karwacki JJ; Singharaj P
    Mil Med; 1989 Oct; 154(10):500-2. PubMed ID: 2515474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mefloquine has more adverse effects than other drugs for malaria prophylaxis.
    Eaton L
    BMJ; 2009 Oct; 339():b4167. PubMed ID: 19825970
    [No Abstract]   [Full Text] [Related]  

  • 37. The adverse effects of mefloquine in deployed military personnel.
    Adshead S
    J R Nav Med Serv; 2014; 100(3):232-7. PubMed ID: 25895400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A malaria outbreak following a British military deployment to Sierra Leone.
    Tuck JJ; Green AD; Roberts KI
    J Infect; 2003 Oct; 47(3):225-30. PubMed ID: 12963384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethical challenges experienced by UK military medical personnel deployed to Sierra Leone (operation GRITROCK) during the 2014-2015 Ebola outbreak: a qualitative study.
    Draper H; Jenkins S
    BMC Med Ethics; 2017 Dec; 18(1):77. PubMed ID: 29258519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malaria chemoprophylaxis with atovaquone-proguanil: is a shorter regimen fully protective?
    Grobusch MP
    J Travel Med; 2014; 21(2):79-81. PubMed ID: 24593022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.